We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs (Treg)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01210664
Recruitment Status : Active, not recruiting
First Posted : September 28, 2010
Last Update Posted : May 20, 2016
Juvenile Diabetes Research Foundation
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of California, San Francisco